Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-06

FDA Approved: ROPINIROLE — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved a supplemental application for ropinirole from Accord Healthcare Inc., indicating the generic product's approval under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ropinirole (ropinirole)

Snippet

SUPPL AP for ROPINIROLE (ROPINIROLE)